Cargando…
Targeting KRAS in Pancreatic Ductal Adenocarcinoma: The Long Road to Cure
SIMPLE SUMMARY: Pancreatic ductal adenocarcinoma is one of the deadliest malignancies in humans. Despite advances in systemic therapy, prognosis still remains poor. However, recent discoveries in the main biological event in pancreatic carcinogenesis, the KRAS mutation, have broadened our understand...
Autores principales: | de Jesus, Victor Hugo Fonseca, Mathias-Machado, Maria Cecília, de Farias, João Paulo Fogacci, Aruquipa, Marcelo Porfirio Sunagua, Jácome, Alexandre A., Peixoto, Renata D’Alpino |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605759/ https://www.ncbi.nlm.nih.gov/pubmed/37894382 http://dx.doi.org/10.3390/cancers15205015 |
Ejemplares similares
-
Biomarkers in Anal Cancer: Current Status in Diagnosis, Disease Progression and Therapeutic Strategies
por: Mathias-Machado, Maria Cecília, et al.
Publicado: (2022) -
Current Molecular Profile of Gastrointestinal Stromal Tumors and Systemic Therapeutic Implications
por: Mathias-Machado, Maria Cecilia, et al.
Publicado: (2022) -
PD-L1 testing in advanced gastric cancer—what physicians who treat this disease must know—a literature review
por: Peixoto, Renata D’Alpino, et al.
Publicado: (2023) -
Clinical Response to Sorafenib in a Patient with Metastatic Colorectal Cancer and FLT3 Amplification
por: Moreira, Raphael Brandão, et al.
Publicado: (2015) -
Tonic-Clonic Seizure following Cytoreductive Surgery with Intraperitoneal Oxaliplatin: A Case Report and Review of the Literature
por: Tsukamoto, Jessica Sayuri, et al.
Publicado: (2016)